Medical Condition

colorectal neoplasms

Total Trials

8

Recruiting Now

8

Trial Phases

Phase 1, Phase 2, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for colorectal neoplasms sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — colorectal neoplasms Clinical Trials

How many clinical trials are currently recruiting for colorectal neoplasms?

ClinicalMetric currently tracks 8 actively recruiting clinical trials for colorectal neoplasms, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for colorectal neoplasms?

colorectal neoplasms research spans Phase 1 (3 trials), Phase 2 (3 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a colorectal neoplasms clinical trial?

Eligibility criteria for colorectal neoplasms trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 3

Top Sponsors

National Cancer Institute (NCI) 2 trials

QuantumLeap Healthcare Collaborative 1 trial

Seagen, a wholly owned subsidiary of Pfizer 1 trial

China Medical University, China 1 trial

Sergey Orlov, MD 1 trial

Recruiting Clinical Trials

NCT05868226 Phase 1, Phase 2

Recruiting

PRE-ISPY Phase I/II Oncology Platform Program

QuantumLeap Healthcare Collabo...

View Trial →

NCT04222413 Phase 1

Recruiting

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

National Cancer Institute (NCI...

View Trial →

NCT06131840 Phase 1

Recruiting

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

Enrollment

914 pts

Location

United States, Canad...

Sponsor

Seagen, a wholly owned subsidi...

View Trial →

NCT07262840

Recruiting

Health Behavior Change in High-Risk Colorectal Cancer Individuals

China Medical University, Chin...

View Trial →

NCT05286814 Phase 2

Recruiting

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

National Cancer Institute (NCI...

View Trial →

NCT06949982 Phase 2

Recruiting

Efficacy And Safety Of Hydroxychloroquine Combined With Methotrexate, Capecitabine And Bevacizumab Vs. Regorafenib In Participants With Refractory Metastatic Colorectal Cancer With Mutations In RAS Genes

AI-Based Stool Image Analysis for Colorectal Neoplasia Risk Assessment

Servicio de Salud Metropolitan...

View Trial →

NCT07222800 Phase 3

Recruiting

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Enrollment

800 pts

Location

United States, Argen...

Sponsor

Pfizer

View Trial →

Related Conditions

metastatic colorectal cancer mcrc (2) her2 positive breast cancer (1) metastatic cancer (1) metastatic breast cancer (1) metastatic (1) her2 positive metastatic breast cancer (1) her2 mutation related tumors (1) her 2 protein overexpression (1) her2 negative breast cancer (1) triple negative breast cancer (1) hr positive (1) hormone receptor positive breast cancer (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology